Among them, the expression levels of CD8A, CD8B, GZMA, GZMB, and PRF1 were used to evaluate the infiltration levels of tumor cytotoxic T lymphocytes (CTLs), and a high-CTL-infiltration group has been related to significantly prolonged survival time of patients receiving immunotherapy (7). Here, CD8B is linked to neoplasm.